

Alcobra Pharmaceuticals develops treatment for attention deficit hyperactivity disorder.
| Headquarter | Tell, TX United States of America |
|---|---|
| Website | www.alcobra-pharma.com/ |
| Founding Date | 2007 |
| Company Status | Private |
Alcobra Ltd. competitors include Amicus Therapeutics, Array BioPharma, Big Cartel, and Zogenix. Alcobra Ltd. ranks 5th in Overall Culture Score on Comparably vs its competitors. See below how Alcobra Ltd. compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.
1 employee at Alcobra Ltd. has reviewed Alcobra Ltd. across various culture dimensions, providing their opinions on items ranging from executive ratings to the pace at work. The latest review was months ago.

The prevailing opinion from Comparably users about their company is that it was very prepared on their first day. Employees concluded that their overall onboarding experience was positive. 73% said their direct manager was helpful with their acclimation during the first 90 days. First impressions are important, and how prepared a company is on your first day leaves a lasting impression.
At this moment no Alcobra Ltd. employees have provided insight into whether or not they clearly understand Alcobra Ltd. KPIs and OKRs.

No Recent Jobs found for Alcobra Ltd. on Comparably
Mark that you are interested and we will alert you when there are new positions available listed on Comparably

Who is the CEO of Alcobra Ltd.?
Alcobra Ltd. CEO is David Baker, their score by employees is 40
Who are Alcobra Ltd. competitors?
Alcobra Ltd. main competitors are Amicus Therapeutics, Array BioPharma, Big Cartel, Zogenix
Who is Alcobra Ltd. leadership?
are part of Alcobra Ltd. leadership, David Baker is the CEO